NETs激活了巨细胞中的GAS6-AXL-NLRP3轴,以驱动吗啡耐受性
Qingyan Tian1, Haiyue Guo1, Mengyao Zhang1
1Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China.
Cell communication and signaling : CCS
|April 11, 2025
概括
中性粒细胞外细胞陷 (NETs) 通过激活GAS6-AXL-TLR7/9通路来驱动吗啡耐受性. 破坏NET或这个轴提供了一种新的策略,可以有效地管理疼痛.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 疼痛研究 疼痛研究
背景情况:
- 吗啡耐受性是管理严重疼痛的重大临床障碍.
- 了解吗啡耐受性的分子机制对于开发有效治疗非常重要.
研究的目的:
- 研究中性粒细胞外细胞陷 (NETs) 在发展吗啡耐受性的作用.
- 阐明涉及NETs介导的吗啡耐受性的特定分子途径.
- 确定对抗吗啡耐受性的潜在治疗点.
主要方法:
- 在C57BL/6J小鼠中使用尾部试验评估吗啡耐受性.
- 通过Western blotting,实时PCR,ELISA和共聚焦显微镜对NETs形成和巨吞的研究.
- 评估GAS6-AXL-TLR7/9-NLRP3炎症酶通路和细胞因子的产生 (IL-1β,IL-18).
主要成果:
- 在患有吗啡耐受性的患者和动物中观察到升高的NETs水平.
- 对NETs形成的遗传或药理障碍显著减轻了对吗啡的耐受性.
- 吗啡诱导的NETs通过GAS6-AXL轴被巨细胞吞,激活TLR7/9-NLRP3炎症体并增加IL-1β/IL-18,从而促进耐受性.
- 针对该途径的组件 (Axl,Gas6,Nlrp3) 或使用IL-1受体抗剂 (anakinra) 或IL-18BP改善了吗啡耐受性.
结论:
- 吗啡诱导的NETs是发展止痛药耐受性的关键因素.
- GAS6-AXL-TLR7/9信号轴代表了克服吗啡耐受性的新型治疗目标.
- 旨在破坏NET或调节这一轴的干预措施有望改善疼痛管理策略.
相关概念视频
Analgesia and Pain Management
402
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
402
Opioid Receptors: Overview
346
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
346
Opioid Analgesics: Morphine and Other Natural Cogeners
142
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
142
Opioid Analgesics: Synthetic and Semisynthetic Opioids
181
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
181
Nociception
27.6K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.6K
GPCR Desensitization
5.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.6K


